トランスクリプション延長因子は,芽細胞腫における in vivo がんの依存性を表している
Tyler E Miller1,2,3,4, Brian B Liau5,6,7, Lisa C Wallace1
1Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Nature
|July 6, 2017
まとめ
この研究は,イン・ビボスクリーニングを用いて,膠芽細胞腫の新たな治療標的を明らかにした. JMJD6のような転写延長因子をターゲットにすることで,膠原細胞腫の生存率が向上します.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- グリオブラストーマは致命的な脳癌で 治療の選択肢は限られています
- 現在の薬の発見はしばしば in vitro モデルに依存しており,これは in vivo 腫瘍の微小環境を反映していない可能性があります.
研究 の 目的:
- グリオブラストーマの標的発見のための in vivo スクリーニングプラットフォームを開発し,利用する.
- インビヴォ・グリオブラストーマの微小環境に特有の新しい治療標的を特定する.
主な方法:
- オーソトピック患者由来異種移植モデルに対するプールRNA干渉 (RNAi) スクリーニング.
- 生存依存性を比較するために,同時に in vitro と in vivo のスクリーンを実施した.
- 機能的な腫瘍の微小環境で高通量ネガティブ選択スクリーニングを使用した.
主要な成果:
- in vivoおよびin vitroスクリーニングでは,重複しないエッセンシャルクロマチンと転写レギュレータのセットが特定されました.
- グリオブラストーマの生存における重要なインビボ依存性として,転写の休止放出と延長因子を発見した.
- JMJD6をインビボでエンハンサー主導の転写適応を媒介する重要な因子として特定した.
- JMJD6または延長因子をターゲットにすることで,臨床前における芽細胞腫の生存期間が延長されました.
結論:
- In vivoのフェノタイプスクリーニングは,in vitroの方法では見逃された新しいがん依存性を発見するのに強力です.
- 転写延長装置は 結晶芽細胞腫の有望な治療戦略です
- JMJD6および関連因子をターゲットにすることで 膠芽細胞腫の治療の新たな道が開けます
さらに関連する動画
関連する概念動画
Transcription Elongation Factors
14.2K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
14.2K
Transcription Elongation Factors
4.9K
4.9K
General Transcription Factors
7.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.3K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Transcription Factors
83.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
83.1K
The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K


